Recital 3, Regulation (EU) 2024/1398

In forcesince 14 Mar 2024

There are substantial delays in the completion of the work programme. The Commission presented a detailed assessment of this situation to the Council and the European Parliament in the implementation report of Regulation (EU) No 528/2012 in June 2021 [The Report is available at this link: https://eur-lex.europa.eu/legal-content/EN/TXT/?qid=1623326515401&uri=CELEX%3A52021DC0287 and the Staff Working Document, which presents detailed evidence for the findings outlined in the report, is available here: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A52021SC0128&qid=1623670527414]. The main reasons for them are the lack of resources allocated in Member States, delays by applicants in submitting additional data, complex technical questions on specific dossiers that need to be resolved, evolution of technical guidance and the new scientific criteria for the determination of endocrine disrupting properties introduced by Commission Delegated Regulation (EU) 2017/2100 [Commission Delegated Regulation (EU) 2017/2100 of 4 September 2017 setting out scientific criteria for the determination of endocrine-disrupting properties pursuant to Regulation (EU) No 528/2012 of the European Parliament and Council (OJ L 301, 17.11.2017, p. 1, ELI: http://data.europa.eu/eli/reg_del/2017/2100/oj).], which triggered the need for further data and further assessments.